A special thank you to our CRN member companies who sent their distinguished experts to provide the rich, valuable content presented at our 10th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements.
Alkemist Labs
Anthony Fontana
Laboratory Director
Amin Talati Wasserman LLP
Rend Al-Mondhiry
Partner
Amway
Michelle Stout
Regulatory Policy Director
Arnold & Porter Kaye Scholer LLP
Raqiyyah Pippins
Partner
BakerHostetler
Amy Ralph Mudge
Partner
Bodybuilding.com
Anastasia Gilmartin
Director of Regulatory Compliance, Counsel
ChromaDex
Andrew Shao, Ph.D.
Senior Vice President, Global Scientific & Regulatory Affairs
Cronos Group
Thomas Cohn
Global Head Of Regulatory & Product
Garden of Life
Jeff Brams
Chief Innovation & Legal Officer
Global Retailer and Manufacturer Alliance
Mike Finamore
CEO
GSK
Lauren Quinn
Vice President and Head, US Regulatory Affairs
Haynes and Boone LLP
Suzie Trigg
Partner
Hogan Lovells LLP
Xin Tao
Counsel
Hyman, Phelps, & McNamara, P.C.
Ricardo Carvajal
Director
Kelly Drye & Warren LLP
Donnelly McDowell
Partner
Lathrop GPM
Katie Bond
Partner
Nature's Way
Tara Falsani
General Counsel, Vice President and Secretary
Nestlé Health Science
Jennifer Boyd
Senior Director, Regulatory Affairs, US & International
Greg Fortsch
Associate General Counsel for Regulatory Affairs
Perkins Coie
Jasmine Wetherell
Counsel
Pharmavite
Mohamed Koroma
Director, Research and Development
Sidley Austin LLP
Diane McEnroe
Partner
Venable LLP
Claudia Lewis
Partner
Vicente Sederberg LLP
Andrea Golan
Attorney
XYMOGEN
Taneesha Rogers, J.D.
Director of Regulatory Affairs
"It’s such an important time to come together for in-depth discussions of the legal and regulatory challenges our industry faces. Our ability to innovate and to deliver on growing consumer demand for safe, effective, and beneficial dietary supplement and functional food products depends on being able to maneuver the changing legal and regulatory landscape as well. This conference always delivers the latest advice, strategic insights to guide decisions, provocative conversations and the camaraderie that comes from exchanging ideas and learning with your colleagues."
Steve Mister
President & CEO, CRN
"Legal and regulatory issues are front and center for our industry, affecting supplements used for decades like n-acetyl-L-cysteine (NAC) and newer formulations such as hemp derived cannabidiol (CBD) alike, with the potential to affect other ingredients. Our agenda of presenters helped participants prepare for what’s ahead."
Tara Falsani
VP and General Counsel, Nature's Way